An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

Mostrar otras versiones (1)

The emergence of the highly transmissible B.1.1.529 Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is concerning for antibody countermeasure efficacy because of the number of mutations in the spike protein. In this study, we tested a panel of anti-receptor-binding do...

Descripción completa

Detalles Bibliográficos
Autores principales: VanBlargan, Laura A., Errico, John M., Halfmann, Peter J., Zost, Seth J., Crowe, James E., Purcell, Lisa A., Kawaoka, Yoshihiro, Corti, Davide, Fremont, Daved H., Diamond, Michael S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767531/
https://www.ncbi.nlm.nih.gov/pubmed/35046573
http://dx.doi.org/10.1038/s41591-021-01678-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767531/
https://www.ncbi.nlm.nih.gov/pubmed/35046573
http://dx.doi.org/10.1038/s41591-021-01678-y

Ejemplares similares